Testing a nerve-blocking shot for recent mild TBI
Treatments studied
Part of Brain & nervous system, Injuries & trauma clinical trials.
This Phase 2 study tests a medication that blocks a pain signal (a CGRP receptor antibody) in people who recently had a mild traumatic brain injury (mTBI) and are also dealing with post-traumatic headache (PTH). The goal is to see if it can reduce symptoms and improve recovery after the injury.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Be between 18 and 50 years old
- Have had a mild TBI within the last 7 days
- Have had post-traumatic headache within the last 7 days
- Be able to sign consent and likely be able to stay in the area for the study
- Have a regular healthcare provider who can handle standard care for your TBI/headache (including imaging if needed)
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests whether people with long-term headache after a mild head injury have an abnormal reaction to a substance called adrenomedullin, which may play a role in causing headaches. You will receive adrenomedullin and a placebo in separate sessions to see how your headache responds.
This study tests if ketamine infusions or a stellate ganglion block (a numbing injection near the neck) can help people with long-term headaches or PTSD after a traumatic brain injury. It compares these treatments alone and together.
This trial tests if Botox injections can reduce headache days in people with persistent headaches after a mild head injury. It may help if you have headaches at least 15 days a month.
This study tests whether a type of brain stimulation called TMS can help people with ongoing symptoms after a mild concussion. If you have had concussion symptoms for at least a month but less than a year, you may be able to join.
This study looks at treatment for ongoing headache that starts or gets worse after a mild or moderate head/neck injury in veterans or active-duty service members. It may help by testing an approach aimed at reducing headache burden and improving daily functioning.
This trial tests if a medication called eptinezumab can help stop headaches that start after a head injury. If you have new headaches since your injury and they happen within the first 8 weeks, this study may offer early treatment.
Hear when a new Posttraumatic Headache trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.